These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4547023)

  • 21. [Effect of Cladonia alpestris on Trichomonas vaginalis in vitro].
    Wu J; Zhang M; Ding D; Tan T; Yan B
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):126-9. PubMed ID: 7554162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative drugs against Trichomonas vaginalis.
    Mahdi NK; Gany ZH; Sharief M
    East Mediterr Health J; 2006 Sep; 12(5):679-84. PubMed ID: 17333809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semisynthetic derivatives of purpuromycin as potential topical agents for vaginal infections.
    Trani A; Dallanoce C; Panzone G; Ripamonti F; Goldstein BP; Ciabatti R
    J Med Chem; 1997 Mar; 40(6):967-71. PubMed ID: 9083486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiphlogistic and antimicrobial action of 13 acrylic acids].
    Crescenzi E; Marazzi-Uberti E; Coppi G
    Arch Ital Sci Farmacol; 1964; 14(3):267-71. PubMed ID: 5880660
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiments on the influence of metabolites and antimetabolites on the model of Trichomonas vaginalis. X. Experiments with amino-acids].
    Christow CP
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):390-3. PubMed ID: 4145215
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis.
    Blaha C; Duchêne M; Aspöck H; Walochnik J
    J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A strain of Trichomonas vaginalis with reduced sensitivity for metronidazole].
    Dijkmans BA; Polderman AM; Heintz AP; van Furth R
    Ned Tijdschr Geneeskd; 1982 Nov; 126(48):2193-5. PubMed ID: 6983659
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and antimicrobial activity of some new derivatives of 6,12-dihydroindolo[2,1-b]quinazolin-6,12-dione.
    Grandolini G; Ambrogi V; Perioli L; Giannangeli M; Jovicevic L; Rossi V
    Farmaco; 1997 Nov; 52(11):679-83. PubMed ID: 9550094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure-activity correlations in the series of antimicrobially active nitrothiazoles].
    Kutter E; Machleidt H; Reuter W; Sauter R; Wildfeuer A
    Arzneimittelforschung; 1972 Jun; 22(6):1045-54. PubMed ID: 4559156
    [No Abstract]   [Full Text] [Related]  

  • 30. [Disparaged leukorrhea and resistant forms of Trichomonas vaginalis].
    Hainaux H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):367-9. PubMed ID: 4549774
    [No Abstract]   [Full Text] [Related]  

  • 31. On antimicrobial activity of 3'-phenylspiro[3H-indole-3, 2'-thiazolidine]-2,4' (1H)-diones.
    Diurno MV; Mazzoni O; Piscopo E; Bolognese A
    Farmaco; 1993 Mar; 48(3):435-41. PubMed ID: 8323674
    [No Abstract]   [Full Text] [Related]  

  • 32. [In vitro studies on the identification of metronidazole resistant strains of Trichomonas vaginalis (author's transl)].
    Meingassner JG; Stockinger K
    Z Hautkr; 1981 Jan; 56(1):7-15. PubMed ID: 6971538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.
    Neurath AR; Strick N; Li YY; Lin K; Jiang S
    Biologicals; 1999 Mar; 27(1):11-21. PubMed ID: 10441398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synthesis and antiparasitic activity of new N-alkyl derivatives of 1-(nitrophenyl)-3-(methyl-3-indolyl)-prop-2-ene-1-ones (nitroindolylchalcones)].
    Kirkiacharian S; Alaoui MA; Ouidren M; Gayral P
    Ann Pharm Fr; 1996; 54(6):272-5. PubMed ID: 9008902
    [No Abstract]   [Full Text] [Related]  

  • 35. A quantitative resazurin assay to determinate the viability of Trichomonas vaginalis and the cytotoxicity of organic solvents and surfactant agents.
    Duarte M; Giordani RB; De Carli GA; Zuanazzi JA; Macedo AJ; Tasca T
    Exp Parasitol; 2009 Oct; 123(2):195-8. PubMed ID: 19619538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis.
    Pan CY; Chen JY; Lin TL; Lin CH
    Peptides; 2009 Jun; 30(6):1058-68. PubMed ID: 19463737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of antibacterial and antiparasitic activities of six Moroccan medicinal plants.
    Larhsini M; Oumoulid L; Lazrek HB; Wataleb S; Bousaid M; Bekkouche K; Markouk M; Jana M
    Therapie; 1999; 54(6):763-5. PubMed ID: 10709454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-resistant Trichomonas vaginalis.
    Commun Dis Rep CDR Wkly; 1993 Jul; 3(31):141. PubMed ID: 7689025
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis of some 4-oxo-delta 2-thiazolin-2-ylhydrazones as potential antiprotozoal agents.
    Alves AJ; Leite AC; De Santana DP; Beltrao TM; Coelho MR; Gayral P
    Farmaco; 1993 Aug; 48(8):1167-71. PubMed ID: 8216678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.
    Carta A; Loriga M; Paglietti G; Mattana A; Fiori PL; Mollicotti P; Sechi L; Zanetti S
    Eur J Med Chem; 2004 Feb; 39(2):195-203. PubMed ID: 14987828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.